Triopsy Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1.85M

  • Investors
  • 2

Triopsy General Information

Description

Developer of 3D prostate biopsy technology designed for accurate cancer diagnosis. The company's technology uses an integrated pathology system for more precise specimen handling as well as for proper tissue collection, enabling medical practitioners to diagnose and treat patients suspected of having prostate cancer.

Contact Information

Website
www.triopsy.com
Formerly Known As
3DBiopsy
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 12635 East Montview Boulevard
  • Suite 100
  • Aurora, CO 80045
  • United States
+1 (800)
Primary Industry
Diagnostic Equipment
Other Industries
Decision/Risk Analysis
Vertical(s)
Corporate Office
  • 12635 East Montview Boulevard
  • Suite 100
  • Aurora, CO 80045
  • United States
+1 (800)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Triopsy Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 28-Feb-2024 $1.85M Completed Generating Revenue
3. Angel (individual) 28-Dec-2020 Completed Generating Revenue
2. Angel (individual) 19-Oct-2018 $850K $2.29M Completed Startup
1. Seed Round 06-Jun-2017 $1.44M $1.44M Completed Startup
To view Triopsy’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Triopsy Patents

Triopsy Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210068750-A1 Three-dimensional biopsy imaging and planning system and method Inactive 09-Sep-2019
EP-3522793-A4 Biopsy actuator assembly Pending 10-Oct-2016
EP-3522793-A1 Biopsy actuator assembly Pending 10-Oct-2016
AU-2017344031-A1 Biopsy actuator assembly Inactive 10-Oct-2016
US-20190374209-A1 Biopsy actuator assembly Inactive 10-Oct-2016 A61B10/0275
To view Triopsy’s complete patent history, request access »

Triopsy Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Triopsy Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioVentures Investors Venture Capital Minority
Clean Energy Venture Group Venture Capital Minority
To view Triopsy’s complete investors history, request access »

Triopsy FAQs

  • When was Triopsy founded?

    Triopsy was founded in 2012.

  • Where is Triopsy headquartered?

    Triopsy is headquartered in Aurora, CO.

  • What is the size of Triopsy?

    Triopsy has 5 total employees.

  • What industry is Triopsy in?

    Triopsy’s primary industry is Diagnostic Equipment.

  • Is Triopsy a private or public company?

    Triopsy is a Private company.

  • What is Triopsy’s current revenue?

    The current revenue for Triopsy is .

  • How much funding has Triopsy raised over time?

    Triopsy has raised $4.18M.

  • Who are Triopsy’s investors?

    BioVentures Investors and Clean Energy Venture Group have invested in Triopsy.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »